IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 149 filers reported holding IMPAX LABORATORIES INC in Q2 2013. The put-call ratio across all filers is 2.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $248,000 | +28.5% | 14,881 | -2.3% | 0.00% | 0.0% |
| Q1 2017 | $193,000 | -74.4% | 15,233 | -73.2% | 0.00% | -75.0% |
| Q4 2016 | $754,000 | -87.0% | 56,893 | -76.7% | 0.00% | -86.2% |
| Q3 2016 | $5,785,000 | +71.0% | 244,090 | +130.9% | 0.03% | +45.0% |
| Q1 2016 | $3,384,000 | +832.2% | 105,692 | +1143.4% | 0.02% | +900.0% |
| Q4 2015 | $363,000 | -92.7% | 8,500 | -94.0% | 0.00% | -92.9% |
| Q3 2015 | $4,957,000 | +99040.0% | 140,762 | +140662.0% | 0.03% | – |
| Q2 2015 | $5,000 | -98.4% | 100 | -99.2% | 0.00% | -100.0% |
| Q3 2014 | $305,000 | -88.5% | 12,884 | -87.2% | 0.00% | -92.3% |
| Q1 2014 | $2,650,000 | +414.6% | 100,313 | +287.7% | 0.03% | +333.3% |
| Q2 2013 | $515,000 | – | 25,873 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |